| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M513286200 |
| P8608 | Fatcat ID | release_vdswbk324zgm7fvvp2jcivoeqi |
| P932 | PMC publication ID | 1457055 |
| P698 | PubMed publication ID | 16517601 |
| P50 | author | Paul G. Thomas | Q40438282 |
| Lawrence M Pfeffer | Q56437807 | ||
| Ramin Homayouni | Q71582235 | ||
| Matthew R Sandbulte | Q87746103 | ||
| Richard Webby | Q89595126 | ||
| P2093 | author name string | Lai Wei | |
| P2860 | cites work | Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells | Q24559989 |
| Identifying biological themes within lists of genes with EASE | Q24630875 | ||
| Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins | Q27860890 | ||
| A novel influenza A virus mitochondrial protein that induces cell death. | Q27863709 | ||
| On the role of IRF in host defense | Q28201598 | ||
| Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein | Q28216526 | ||
| Functional diversity of Mx proteins: variations on a theme of host resistance to infection | Q28585853 | ||
| Signaling to NF-kappaB | Q29547844 | ||
| An essential role for NF-kappaB in preventing TNF-alpha-induced cell death | Q29614707 | ||
| Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus | Q33177702 | ||
| A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge | Q33801952 | ||
| Immune and other responses to viral infections. | Q33882018 | ||
| IFNalpha/beta promotes cell survival by activating NF-kappa B | Q35570411 | ||
| p47 GTPases: regulators of immunity to intracellular pathogens | Q35709631 | ||
| Constitutive expression of an ISGF2/IRF1 transgene leads to interferon-independent activation of interferon-inducible genes and resistance to virus infection | Q40066440 | ||
| Active NF-kappaB signalling is a prerequisite for influenza virus infection. | Q40532649 | ||
| Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. | Q40767950 | ||
| The state of the STATs: recent developments in the study of signal transduction to the nucleus | Q41382841 | ||
| Interferon alpha /beta promotes cell survival by activating nuclear factor kappa B through phosphatidylinositol 3-kinase and Akt. | Q43559916 | ||
| Inhibition of JNK activation through NF-kappaB target genes | Q43802523 | ||
| Role of nuclear factor-kappaB in the antiviral action of interferon and interferon-regulated gene expression. | Q44886662 | ||
| Modification of the Stat1 SH2 domain broadly improves interferon efficacy in proportion to p300/CREB-binding protein coactivator recruitment | Q46656248 | ||
| Mx proteins: mediators of innate resistance to RNA viruses | Q47932415 | ||
| Expression, purification, and characterization of rat interferon-beta, and preparation of an N-terminally PEGylated form with improved pharmacokinetic parameters | Q47995804 | ||
| Presentation of an influenza nucleoprotein epitope incorporated into the H-2Db signal sequence requires the transporter-associated with antigen presentation | Q71968321 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 11678-11684 | |
| P577 | publication date | 2006-03-03 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | NFkappaB negatively regulates interferon-induced gene expression and anti-influenza activity | |
| P478 | volume | 281 |
| Q33471485 | 20-Hydroxycholecalciferol, product of vitamin D3 hydroxylation by P450scc, decreases NF-kappaB activity by increasing IkappaB alpha levels in human keratinocytes |
| Q30410798 | Activity of ultra-low doses of antibodies to gamma-interferon against lethal influenza A(H1N1)2009 virus infection in mice. |
| Q36984855 | Altered transcriptome signature of phenotypically normal skin fibroblasts heterozygous for CDKN2A in familial melanoma: relevance to early intervention |
| Q34027569 | An interferon response gene signature is associated with the therapeutic response of hepatitis C patients |
| Q42253508 | Avian-derived NS gene segments alter pathogenicity of the A/Puerto Rico/8/34 virus. |
| Q38387800 | Bioinformatic analysis reveals cRel as a regulator of a subset of interferon-stimulated genes |
| Q28276884 | Confronting an influenza pandemic with inexpensive generic agents: can it be done? |
| Q37151086 | Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway. |
| Q35728237 | Control of type I interferon-induced cell death by Orai1-mediated calcium entry in T cells |
| Q29617418 | Crosstalk in NF-κB signaling pathways |
| Q55283462 | Development of a preclinical humanized mouse model to evaluate acute toxicity of an influenza vaccine. |
| Q34742996 | Distinct roles for the NF-kappa B RelA subunit during antiviral innate immune responses |
| Q34648885 | Does cytokine signaling link sphingolipid metabolism to host defense and immunity against virus infections? |
| Q36225743 | EHMT1 protein binds to nuclear factor-κB p50 and represses gene expression |
| Q37117819 | Efficient influenza A virus replication in the respiratory tract requires signals from TLR7 and RIG-I. |
| Q27315954 | Exacerbated innate host response to SARS-CoV in aged non-human primates |
| Q58180784 | Exploited defense: how influenza viruses take advantage of antiviral signaling responses |
| Q33334070 | Genomic-based high throughput screening identifies small molecules that differentially inhibit the antiviral and immunomodulatory effects of IFN-alpha |
| Q35225690 | Host candidate gene polymorphisms and clearance of drug-resistant Plasmodium falciparum parasites |
| Q37047096 | IL-1beta causes an increase in intestinal epithelial tight junction permeability |
| Q39612799 | IQGAP2 is a novel interferon-alpha antiviral effector gene acting non-conventionally through the NF-κB pathway |
| Q34785589 | Identification of Host Kinase Genes Required for Influenza Virus Replication and the Regulatory Role of MicroRNAs. |
| Q28541723 | In vitro anti-influenza virus activities of a new lignan glycoside from the latex of Calotropis gigantea |
| Q38301869 | Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling |
| Q33383235 | Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression |
| Q39297691 | Influenza A virus-encoded NS1 virulence factor protein inhibits innate immune response by targeting IKK. |
| Q37247082 | Influenza viruses and the NF-kappaB signaling pathway - towards a novel concept of antiviral therapy |
| Q41885464 | Inhibition of interferon response by cystatin B: implication in HIV replication of macrophage reservoirs |
| Q36172960 | Inhibition of type I interferon-mediated antiviral action in human glioma cells by the IKK inhibitors BMS-345541 and TPCA-1. |
| Q27489605 | Innate immunity to influenza virus: implications for future therapy |
| Q31083397 | Interferon-resistant Daudi cell line with a Stat2 defect is resistant to apoptosis induced by chemotherapeutic agents |
| Q37997045 | Interferons as biomarkers and effectors: lessons learned from animal models. |
| Q30375026 | Interplay between influenza A virus and host factors: targets for antiviral intervention. |
| Q43200840 | Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity |
| Q37686230 | MiRNA203 suppresses the expression of protumorigenic STAT1 in glioblastoma to inhibit tumorigenesis |
| Q47852882 | MicroRNA203a suppresses glioma tumorigenesis through an ATM-dependent interferon response pathway. |
| Q37110701 | Mitogen-activated protein kinase-activated kinase RSK2 plays a role in innate immune responses to influenza virus infection |
| Q48097634 | Modeling for influenza vaccines and adjuvants profile for safety prediction system using gene expression profiling and statistical tools |
| Q90674899 | Molecular Insights into Muscle Homeostasis, Atrophy and Wasting |
| Q52603349 | Molecular identification and transcriptional regulation of porcine IFIT2 gene. |
| Q38175584 | Multifarious determinants of cytokine receptor signaling specificity. |
| Q80809479 | NF-kappaB p50 and p65 subunits control intestinal homeostasis |
| Q37981941 | NF-κB as a potential therapeutic target in microbial diseases |
| Q36877132 | New approach reveals CD28 and IFNG gene interaction in the susceptibility to cervical cancer |
| Q42948998 | Specific NFkappaB subunit activation and kinetics of cytokine induction in adenoviral keratitis. |
| Q59357572 | Strand-Specific Dual RNA Sequencing of Bronchial Epithelial Cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions |
| Q43171612 | Study on the anti-H1N1 virus effects of quercetin and oseltamivir and their mechanism related to TLR7 pathway. |
| Q34412329 | Suppression of IFN-induced transcription underlies IFN defects generated by activated Ras/MEK in human cancer cells |
| Q58180699 | Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy |
| Q37123459 | Targeting intracellular signaling: a novel approach to vaccination. |
| Q92606063 | Targeting the proviral host kinase, FAK, limits influenza a virus pathogenesis and NFkB-regulated pro-inflammatory responses |
| Q30425939 | The NF-κB inhibitor SC75741 efficiently blocks influenza virus propagation and confers a high barrier for development of viral resistance |
| Q36246200 | The NS1 protein of influenza A virus blocks RIG-I-mediated activation of the noncanonical NF-κB pathway and p52/RelB-dependent gene expression in lung epithelial cells |
| Q39686446 | The clinically approved proteasome inhibitor PS-341 efficiently blocks influenza A virus and vesicular stomatitis virus propagation by establishing an antiviral state |
| Q35172895 | The oncogenic microRNA-21 inhibits the tumor suppressive activity of FBXO11 to promote tumorigenesis |
| Q36662766 | The role of TRAF2 binding to the type I interferon receptor in alternative NF kappaB activation and antiviral response |
| Q35084134 | The role of nuclear factor κB in the interferon response |
| Q39587742 | The specificity of innate immune responses is enforced by repression of interferon response elements by NF-κB p50 |
| Q40108329 | The virulence factor PA protein of highly pathogenic H5N1 avian influenza virus inhibits NF-κB transcription in vitro |
| Q45370362 | Therapy of experimental influenza virus infection with pyrrolidine dithiocarbamate |
| Q41956875 | Transcription factor regulation and cytokine expression following in vitro infection of primary chicken cell culture with low pathogenic avian influenza virus |
| Q38699299 | Unphosphorylated STAT3 regulates the antiproliferative, antiviral, and gene-inducing actions of type I interferons |
| Q32944490 | Upregulation of miRNA-4776 in influenza virus infected bronchial epithelial cells is associated with downregulation of NFKBIB and increased viral survival |
| Q26830578 | Vitamin D and influenza |
Search more.